Daily MDOI Identifier Registry
Browse, search, and export all registered MDOI identifiers. Use the filters below to narrow results.
1190 total identifiers
| # | Identifier | Title | Resource type | Visibility | Registered | Modified |
|---|---|---|---|---|---|---|
| 551 | 110.0680/CON.2026.00652 | Cost-Effectiveness of Interventions Addressing Loneliness Among Adults: A Systematic Literature Review |
Article | Public | 2026-07-17 | 2026-07-17 |
| 552 | 110.0679/CON.2026.00651 | Impact of Constrained Access to Primary Care on Health-Related Quality of Life |
Article | Public | 2026-07-17 | 2026-07-17 |
| 553 | 110.0678/CON.2026.00650 | Testing the Valuation of the EQ-5D-Y-5L in Adults and Adolescents: Results From a 5-Country Study and Implications for the Descriptive System |
Article | Public | 2026-07-17 | 2026-07-17 |
| 554 | 110.0677/CON.2026.00649 | Testing the Valuation of the EQ-5D-Y-5L in Adults and Adolescents: Results From a 5-Country Study and Implications for the Descriptive System |
Article | Public | 2026-07-17 | 2026-07-17 |
| 555 | 110.0676/CON.2026.00648 | Inequality Aversion in Health: Eliciting Aversion to Univariate Health Inequalities Across Different Health Distributions |
Article | Public | 2026-07-17 | 2026-07-17 |
| 556 | 110.0674/CON.2026.00646 | The Impact of the Inflation Reduction Act’s Drug Price Negotiation Program on Incentives for Clinical Development of New Drugs |
Article | Public | 2026-07-17 | 2026-07-17 |
| 557 | 110.0673/CON.2026.00645 | Patient-Reported Outcomes Now and Into the Future: Multistakeholder Perspectives on Optimizing the Use of Patient-Reported Outcome Evidence in Decision Making Across the US Healthcare Continuum |
Article | Public | 2026-07-17 | 2026-07-17 |
| 558 | 110.0672/CON.2026.00644 | EQ Health and Wellbeing EQ-HWB: A Psychometric Assessment Across 6 Conditions and the General Population in the United Kingdom |
Article | Public | 2026-07-17 | 2026-07-17 |
| 559 | 110.0671/CON.2026.00643 | EQ Health and Wellbeing EQ-HWB: A Psychometric Assessment Across 6 Conditions and the General Population in the United Kingdom |
Article | Public | 2026-07-17 | 2026-07-17 |
| 560 | 110.0670/CON.2026.00642 | APPRAISE: A Tool for Appraising Potential for Bias in Real-World Evidence Studies on Medication Effectiveness or Safety |
Article | Public | 2026-07-17 | 2026-07-17 |
| 561 | 110.0669/CON.2026.00641 | Physician-Directed Reinvestment: A Novel Cost-Savings Framework for Hospital Systems That Leverages Frontline Physicians |
Article | Public | 2026-07-17 | 2026-07-17 |
| 562 | 110.0668/CON.2026.00640 | Zero Dollar Copay Pharmacy Benefit Decreases Healthcare Expenditures Among Members With Type 2 Diabetes of Blue Cross Blue Shield of Louisiana |
Article | Public | 2026-07-17 | 2026-07-17 |
| 563 | 110.0667/CON.2026.00639 | Poor Patient Care Outcomes and Nurse Job Outcomes Associated With Unfavorable Intensive Care Unit and Emergency Department Nurse Work Environments: Implications for Critical Care Medicine |
Article | Public | 2026-07-17 | 2026-07-17 |
| 564 | 110.0666/CON.2026.00638 | Measuring the First Mover Advantage in US Biosimilar Markets |
Article | Public | 2026-07-17 | 2026-07-17 |
| 565 | 110.0665/CON.2026.00637 | Methodological Challenges With Conducting Health Economic Evaluations in the Critical-Care Context |
Article | Public | 2026-07-17 | 2026-07-17 |
| 566 | 110.0664/CON.2026.00636 | Value-Based Commissioning of Mental Health Services in England: A Feasibility Study Using Multicriteria Decision Analysis |
Article | Public | 2026-07-17 | 2026-07-17 |
| 567 | 110.0663/CON.2026.00635 | Cost-Utility Analysis Alongside the GORTEC 2014-01 TPExtreme Trial: TPEx Versus EXTREME as First-Line Treatment in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma |
Article | Public | 2026-07-17 | 2026-07-17 |
| 568 | 110.0661/CON.2026.00633 | Understanding the Role of Clinical and Functional Needs in Home-Visit Nursing Effectiveness: Evidence From South Korea |
Article | Public | 2026-07-17 | 2026-07-17 |
| 569 | 110.0660/CON.2026.00632 | Development and Use of Cognition Bolt-Ons for the EQ-5D-3L and EQ-5D-5L: A Systematic Review |
Article | Public | 2026-07-17 | 2026-07-17 |
| 570 | 110.0659/CON.2026.00631 | Strong Preferences or Simplifying Heuristics? Using Internal Validity Tests and Latent Class Analysis to Better Understand Stated Preference Survey Results. A Case Example in Health Preferences Research |
Article | Public | 2026-07-17 | 2026-07-17 |
| 571 | 110.0658/CON.2026.00630 | Who Needs Real Data Anyway? Exploring the Use of Synthetic Data in Economic Evaluations of Health Interventions |
Article | Public | 2026-07-17 | 2026-07-17 |
| 572 | 110.0657/CON.2026.00629 | Genotype-Specific Tricyclic Antidepressant Dosing in Patients With Major Depressive Disorder: A Trial-Based Economic Evaluation |
Article | Public | 2026-07-17 | 2026-07-17 |
| 573 | 110.0656/CON.2026.00628 | An Assessment of the Maturity of Cancer Survival Data Used in Economic Models for the National Institute for Health and Care Excellence’s Single Technology Appraisals |
Article | Public | 2026-07-17 | 2026-07-17 |
| 574 | 110.0655/CON.2026.00627 | Unravelling Public Preferences for the Use of Artificial Intelligence Mobile Health Applications in Australia |
Article | Public | 2026-07-17 | 2026-07-17 |
| 575 | 110.0654/CON.2026.00626 | Roles of Artificial Intelligence--Based Synthetic Data in Health Economics and Outcomes Research |
Article | Public | 2026-07-17 | 2026-07-17 |
| 576 | 110.0653/CON.2026.00625 | Generative Artificial Intelligence to Automate the Adaptation of Excel Health Economic Models and Word Technical Reports |
Article | Public | 2026-07-17 | 2026-07-17 |
| 577 | 110.0652/CON.2026.00624 | Role of Generative Artificial Intelligence in Assisting Systematic Review Process in Health Research: A Systematic Review |
Article | Public | 2026-07-17 | 2026-07-17 |
| 578 | 110.0651/CON.2026.00623 | The “Artificial Intelligence Statistician”: Utilizing Generative Artificial Intelligence to Select an Appropriate Model and Execute Network Meta-Analyses |
Article | Public | 2026-07-17 | 2026-07-17 |
| 579 | 110.0650/CON.2026.00622 | Use of Large Language Models to Extract Cost-Effectiveness Analysis Data: A Case Study |
Article | Public | 2026-07-16 | 2026-07-17 |
| 580 | 110.0649/CON.2026.00621 | Use of Large Language Models to Extract Cost-Effectiveness Analysis Data: A Case Study |
Article | Public | 2026-07-16 | 2026-07-16 |
| 581 | 110.0648/CON.2026.00620 | Artificial Intelligence in Health Economics and Outcomes Research: Highlighting the Contributions of Early Career Researchers |
Article | Public | 2026-07-16 | 2026-07-16 |
| 582 | 110.0647/CON.2026.00619 | Health Economics and Outcomes Research in the New Era of Artificial Intelligence: Catch Me If You Can |
Article | Public | 2026-07-16 | 2026-07-16 |
| 583 | 110.0646/CON.2026.00618 | ELEVATE-GenAI: Reporting Guidelines for the Use of Large Language Models in Health Economics and Outcomes Research: An ISPOR Working Group Report |
Article | Public | 2026-07-16 | 2026-07-16 |
| 584 | 110.0645/CON.2026.00617 | A Taxonomy of Generative Artificial Intelligence in Health Economics and Outcomes Research: An ISPOR Working Group Report |
Article | Public | 2026-07-16 | 2026-07-16 |
| 585 | 110.0644/CON.2026.00616 | Provider Differences in Costs, Utilization, and Quality of Primary Care for Traumatic Brain Injury in the Military |
Article | Public | 2026-07-16 | 2026-07-16 |
| 586 | 110.0643/CON.2026.00615 | Economic Evaluation of the HEARTS Standardized Hypertension Treatment Program With Fixed-Dose Combination Pills in Chile Primary Care Clinics |
Article | Public | 2026-07-16 | 2026-07-16 |
| 587 | 110.0642/CON.2026.00614 | Comprehensive Access to Semaglutide: Clinical and Economic Implications for Medicare |
Article | Public | 2026-07-16 | 2026-07-16 |
| 588 | 110.0641/CON.2026.00613 | Cost-Effectiveness of Long-Chain Omega-3 Supplementation for the Secondary Prevention of Cardiovascular Disease in the United States |
Article | Public | 2026-07-16 | 2026-07-16 |
| 589 | 110.0640/CON.2026.00612 | Achieving Patient-Centered Value/Health Technology Assessment: Recommendations From a Multistakeholder eDelphi Panel |
Article | Public | 2026-07-16 | 2026-07-16 |
| 590 | 110.0639/CON.2026.00611 | Achieving Patient-Centered Value/Health Technology Assessment: Recommendations From a Multistakeholder eDelphi Panel |
Article | Public | 2026-07-16 | 2026-07-16 |
| 591 | 110.0638/CON.2026.00610 | Cost per Opioid-Free Year: A Systematic Review and Summary Analysis |
Article | Public | 2026-07-16 | 2026-07-16 |
| 592 | 110.0637/CON.2026.00609 | Utility Studies in Rare Diseases: A Systematic Literature Review |
Article | Public | 2026-07-16 | 2026-07-16 |
| 593 | 110.0636/CON.2026.00608 | Do We Always Need a New Preference Study? A Scoping Review of Promising Research Areas for Meta-Analyses and Benefit Transfers of Patient Preference Studies |
Article | Public | 2026-07-16 | 2026-07-16 |
| 594 | 110.0635/CON.2026.00607 | Quality of Care for Patients With Advanced Illness Scale: Development, Preference Elicitation, and Evaluation of Measurement Properties |
Article | Public | 2026-07-16 | 2026-07-16 |
| 595 | 110.0634/CON.2026.00606 | Health State Utilities for Achondroplasia: A Time Trade-Off Study |
Article | Public | 2026-07-16 | 2026-07-16 |
| 596 | 110.0633/CON.2026.00605 | Is There a General Preference for the Worse Off? A Discrete Choice Experiment Using Individually Calibrated Health State Valuations |
Article | Public | 2026-07-16 | 2026-07-16 |
| 597 | 110.0632/CON.2026.00604 | Comparisons of Preferences Toward EQ-5D-Y-3L Health States Between Adult Own and Child Perspectives |
Article | Public | 2026-07-16 | 2026-07-16 |
| 598 | 110.0631/CON.2026.00603 | Validity of the EQ-5D-5L for Routine Assessment in Residential Aged Care: Results From a Feasibility Study |
Article | Public | 2026-07-16 | 2026-07-16 |
| 599 | 110.0630/CON.2026.00602 | Building Blocks of Value Creation Within Value-Based Health Systems: A Delphi Study |
Article | Public | 2026-07-16 | 2026-07-16 |
| 600 | 110.0629/CON.2026.00601 | Use and Potential Misuse of Glucagon-Like Peptide-1 Receptor Agonists in France: A Nationwide Cohort Study |
Article | Public | 2026-07-16 | 2026-07-16 |